# EDGAR Filing Document

**Accession Number:** 0001662982
**File Stem:** 0001651308-23-000038
**Filing Date:** 2023-3
**Character Count:** 11606
**Document Hash:** 00adc228c3a4bb164c0aba0311e263d8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001651308-23-000038.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001651308-23-000038

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230308

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wang Xiaodong
- **CENTRAL INDEX KEY:** 0001662982

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37686
- **FILM NUMBER:** 23725209

**MAIL ADDRESS:**
- **STREET 1:** C/O MOURANT OZANNES CORPORATE SERVICES
- **STREET 2:** 94 SOLARIS AVENUE
- **CITY:** CAMANA BAY, GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1108
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BeiGene, Ltd.
- **CENTRAL INDEX KEY:** 0001651308
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 981209416
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
- **STREET 2:** 94 SOLARIS AVENUE, CAMANA BAY
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1108
- **BUSINESS PHONE:** 13459494123

**MAIL ADDRESS:**
- **STREET 1:** C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
- **STREET 2:** 94 SOLARIS AVENUE, CAMANA BAY
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1108

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wang Xiaodong<br><sub>(Last) (First) (Middle)</sub><br>C/O MOURANT GOVERNANCE SERVICES (CAYMAN)<br>94 SOLARIS AVENUE<br><sub>(Street)</sub><br>CAMANA BAY, GRAND CAYMAN, E9 KY1-1108<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_Chair, Scientific Advisory Brd_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BeiGene, Ltd. [ BGNE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares |  |  |  |  |  |  |  | 5512556 | D |  |
| Ordinary Shares |  |  |  |  |  |  |  | 1127542 | I | See Footnote<sup>(1)</sup> |
| Ordinary Shares |  |  |  |  |  |  |  | 172372 | I | See Footnote<sup>(2)</sup> |
| Ordinary Shares |  |  |  |  |  |  |  | 4058998 | I | See Footnote<sup>(3)</sup> |
| Ordinary Shares |  |  |  |  |  |  |  | 50 | I | See Footnote<sup>(4)</sup> |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | M |  | 67635 | A | $0.13 | 67635 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 3433 | D | 222.9985<sup>(6)</sup> | 64202 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 7458 | D | 224.0088<sup>(7)</sup> | 56744 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 12534 | D | 224.9239<sup>(8)</sup> | 44210 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 400 | D | 225.3475<sup>(9)</sup> | 43810 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 200 | D | 226.6109<sup>(10)</sup> | 43610 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 14077 | D | 225.9541<sup>(11)</sup> | 29533 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 17170 | D | 227.1205<sup>(12)</sup> | 12363 | D |  |
| American Depositary Shares<sup>(5)</sup> | 2023-03-08 |  | S |  | 12363 | D | 227.7809<sup>(13)</sup> | 0 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Share Option (Right to Buy) | $0.01 | 2023-03-08 |  | M |  |  | 879255 | <sup>(14)</sup> | 2023-04-03 | Ordinary Shares | 879255.0 | $0 | 12 | D |  |

---

### Footnotes:

(1) These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

(2) These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

(3) These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.

(4) These securities are held by the spouse of the Reporting Person.

(5) Each American Depositary Share represents 13 Ordinary Shares.

(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.47 to $223.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.47 to $224.46, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.48 to $225.45, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.87 to $225.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.2218 to $227.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.50 to $226.49, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.50 to $227.49, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.50 to $228.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

(14) These securities vest over a five-year period as follows: 20% on April 3, 2014, and the remaining in 48 successive equal monthly installments, subject to continued service.

**Signature:** /s/ Qing Nian, Attorney-in-Fact  
**Date:** 2023-03-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**